You can now read 10 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

The Boston Globe

Business

Irish health system will pay for Vertex drug

Vertex Pharmaceuticals Inc. said Friday that Ireland’s national health care system has agreed to pay for Kalydeco, a Vertex drug designed to treat some patients suffering from cystic fibrosis, a rare and often fatal genetic disease.

In a press release, Cambridge-based Vertex said that the Health Service Executive in the Republic of Ireland will fund Kalydeco for people 6 and older who have a specific mutation of the cystic fibrosis gene.

Loading comments...

You have reached the limit of 10 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week